- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 207/38 - Pyrrolones-2
Détention brevets de la classe C07D 207/38
Brevets de cette classe: 176
Historique des publications depuis 10 ans
|
5
|
10
|
10
|
11
|
3
|
12
|
15
|
7
|
6
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Novartis AG | 10345 |
11 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 176 |
8 |
| The University of Queensland | 663 |
8 |
| The University of British Columbia | 1532 |
7 |
| Conopco, Inc. | 4981 |
6 |
| Bayer Cropscience AG | 1887 |
6 |
| British Columbia Cancer Agency Branch | 184 |
6 |
| Bristol-myers Squibb Company | 4812 |
5 |
| Unilever PLC | 3046 |
5 |
| Ottawa Hospital Research Institute | 111 |
5 |
| University of Ottawa | 231 |
5 |
| Unilever N.V. | 2955 |
4 |
| Syngenta Participations AG | 1587 |
4 |
| Vectus Biosystems Limited | 28 |
3 |
| Beijing Joekai Biotech. LLC | 5 |
3 |
| Bilix Co., Ltd. | 20 |
3 |
| Huscion Co., Ltd. | 10 |
3 |
| Boehringer Ingelheim International GmbH | 4510 |
2 |
| Syngenta Limited | 436 |
2 |
| Bayer Intellectual Property GmbH | 2410 |
2 |
| Autres propriétaires | 78 |